НАРУШЕНИЯ СИСТЕМЫ ГЕМОСТАЗА У ОНКОЛОГИЧЕСКИХ БОЛЬНЫХ С ТРОМБОЗАМИ И ТРОМБОЭМБОЛИЕЙ ЛЕГОЧНОЙ АРТЕРИИ, РАЗВИВШИМИСЯ НА ФОНЕ ПОДОСТРОГО ДИССЕМИНИРОВАННОГО ВНУТРИСОСУДИСТОГО СВЕРТЫВАНИЯ КРОВИстатья
Статья опубликована в журнале из списка RSCI Web of Science
Аннотация:The main chains of haemostatic system (procoagulant, anticoagulant, fibrinolytic, platelet function) were studied in 30 cancer patients with acute thrombosis and thromboembolic of pulmonary artery (VTE). Automatic analyzer STA-R EVOLUTION was used. The patients received low-molecular-weight heparins (LMWH): 200 U/kg once daily or 100 U/kg twice daily. Period VTE was characterized by subacute disseminated intravascular coagulation with consumption of fibrinogen, protrombin, antithrombin III, plasminogen, protein C, significant increase D-dimer, von Willebrand factor. In spite of decrease of coagulation factors and platelet count, the use of LMWHs in therapeutic doses decreased the activity of intravascular coagulation, restore coagulation factors. The use of LMWHs is an effective and adequate method of antithrombotic treatment in oncological patients. Venous thrombosis were no. No cases of pulmonary embolism developed. The antifactor-Xa activity of LMWH was in the therapeutic range for treatment (0,5-1,0 IU/ml). There were no hemorrhagic complications.